VEGFA and age-related macular degeneration: PEDF displays antiangiogenic and anti-inflammatory properties and was tested in combination with the microRNA-mediated inhibition of the vascular endothelial growth factor-A (VEGF-A) to prevent choroidal neovascularization in vasoproliferative retinal diseases, such as AMD.